Posted in | News | Chemical Sensor

Implant Sciences Supplies 50 QS-B220 Desktop Explosives Trace Detectors to German Airports

Implant Sciences Corporation, a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced an important sale of 50 of its QS-B220 desktop explosives trace detectors to several international airports in Germany.

"Among the German airports in this sale was an airport that is consistently recognized as one of the best and busiest airports in Europe. We were thrilled to work with the customer to develop a customized software configuration for the QS-B220 that met their specific requirements, which we then integrated into our newest release of our European Civil Aviation Conference (ECAC)-approved system," stated Dr. Darryl Jones, Implant Sciences' Vice President of Global Sales and Marketing. "Our German customer needed ETD technology that enabled them to screen very high volumes of passengers with an extremely low false alarm rate. The system we optimized out-performed the other ETD systems when tested in side by side airport trials. I'm happy to announce that these systems are shipping today, and this software upgrade will be implemented into our entire installed base of QS-B220s globally in the fall."

"With this sale, we have announced well over 800 systems sold to international EU airports since the end of April," added Implant Sciences' CEO, Dr. Bill McGann. "Our strong chemistry and engineering team is consistently able to deliver on customer requirements. Once again, Implant Sciences has proven that offering the very best performance and a willingness to work with customers to help them improve security is what wins business."

About the QS-B220 Desktop Explosives and Drugs Trace Detector

The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. With significantly lower maintenance requirements than competing systems, the QS-B220 can be deployed for a much lower total cost of ownership than other approved products. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal™ internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    L3Harris Technologies, Inc.. (2019, February 24). Implant Sciences Supplies 50 QS-B220 Desktop Explosives Trace Detectors to German Airports. AZoSensors. Retrieved on October 04, 2024 from https://www.azosensors.com/news.aspx?newsID=9968.

  • MLA

    L3Harris Technologies, Inc.. "Implant Sciences Supplies 50 QS-B220 Desktop Explosives Trace Detectors to German Airports". AZoSensors. 04 October 2024. <https://www.azosensors.com/news.aspx?newsID=9968>.

  • Chicago

    L3Harris Technologies, Inc.. "Implant Sciences Supplies 50 QS-B220 Desktop Explosives Trace Detectors to German Airports". AZoSensors. https://www.azosensors.com/news.aspx?newsID=9968. (accessed October 04, 2024).

  • Harvard

    L3Harris Technologies, Inc.. 2019. Implant Sciences Supplies 50 QS-B220 Desktop Explosives Trace Detectors to German Airports. AZoSensors, viewed 04 October 2024, https://www.azosensors.com/news.aspx?newsID=9968.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.